Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal
July 31, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer
July 10, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Receives the First FDA Clearance for a Complete Stroke Treatment System
April 24, 2023 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical Announces Expansion to New Manufacturing Site in Salt Lake City, Utah
November 16, 2022 09:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical’s Monopoint® Operating Platform Shows 82% First Pass Effect in Independent Study
July 25, 2022 07:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention,...
Route 92 Medical® Announces Publication of Initial SUMMIT NZ Clinical Trial Results Demonstrating 80% First Pass Effect with the 088 Monopoint® Operating Platform
June 06, 2022 16:30 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention,...
Route 92 Medical® Announces Receipt of 40th Patent for its Monopoint® Operating Platform Designed for Neurovascular Intervention
April 26, 2022 15:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical® Announces First Patient Enrollment in the SUMMIT MAX Pivotal Clinical Trial for the Monopoint® Reperfusion System
February 08, 2022 08:00 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in acute ischemic stroke intervention,...
Route 92 Medical Raises $111 Million in Combined Series E and Debt Financing
December 14, 2021 16:10 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced...
Route 92 Medical Announces Appointment of Blaise W. Baxter, M.D., as Chief Clinical Officer
November 30, 2021 16:10 ET
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced...